Measuring What Is Meaningful in Cancer Cachexia Clinical Trials: A Path Forward With Digital Measures of Real-World Physical Behavior
Open Access
- 1 September 2023
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in JCO Clinical Cancer Informatics
- Vol. 7 (7) , e2300055
Abstract
PURPOSE: The burden of cancer cachexia on patients' health-related quality of life, specifically their physical functioning, is well documented, but clinical trials thus far have failed to show meaningful improvement in physical functioning. The purpose of this review is to summarize existing methods of assessing physical function in cancer cachexia, outline a path forward for measuring what is meaningful to patients using digital measures derived from digital health technologies (DHTs), and discuss the current landscape of digital measures from the clinical and regulatory standpoint. DESIGN: For this narrative review, peer-reviewed articles were searched on PubMed, clinical trials records were searched on clinicaltrials.gov, and records of digital measures submitted for regulatory qualification were searched on the US Food and Drug Administration's Drug Development Tool Qualification Program database. RESULTS: There are gaps in assessing aspects of physical function that matter to patients. Existing assessment methods such as patient-reported outcomes and objective performance outcomes have limitations, including their episodic nature and burden to patients. DHTs such as wearable sensors can capture real-world physical behavior continuously, passively, and remotely, and may provide a more comprehensive picture of patients' everyday functioning. Recent regulatory submissions showcase potential clinical implementation of digital measures in various therapeutic areas. CONCLUSION: Digital measures of real-world physical behavior present an opportunity to detect and demonstrate improvements in physical functioning in cancer cachexia, but evidence-based development is critical. For their use in clinical and regulatory decision making, studies demonstrating meaningfulness to patients as well as feasibility and validation are necessary.Keywords
This publication has 110 references indexed in Scilit:
- Insights Into the Reluctance of Patients With Late-Stage Cancer to Adopt Exercise as a Means to Reduce Their Symptoms and Improve Their FunctionJournal of Pain and Symptom Management, 2012
- Clinical Studies on the Treatment of Cancer Cachexia with Megestrol Acetate plus ThalidomideChemotherapy, 2012
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Improvement of physical activity as an alternative objective variable to measure treatment effects of anticachexia therapy in cancer patientsCurrent Opinion in Supportive & Palliative Care, 2010
- Cachexia as a major underestimated and unmet medical need: facts and numbersJournal of Cachexia, Sarcopenia and Muscle, 2010
- Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer CachexiaThe Oncologist, 2010
- Physical activity level as an outcome measure for use in cancer cachexia trials: a feasibility studySupportive Care in Cancer, 2009
- The Prevalence of Concern About Weight Loss and Change in Eating Habits in People with Advanced CancerJournal of Pain and Symptom Management, 2006
- Physical Function in Patients with CancerJournal of Pain and Symptom Management, 2002
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993